Display options
Share it on

Diabetes Metab J. 2014 Jun;38(3):181-6. doi: 10.4093/dmj.2014.38.3.181.

The role of pyruvate dehydrogenase kinase in diabetes and obesity.

Diabetes & metabolism journal

In-Kyu Lee

Affiliations

  1. Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.

PMID: 25003070 PMCID: PMC4083023 DOI: 10.4093/dmj.2014.38.3.181

Abstract

The pyruvate dehydrogenase complex (PDC) is an emerging target for the treatment of metabolic syndrome. To maintain a steady-state concentration of adenosine triphosphate during the feed-fast cycle, cells require efficient utilization of fatty acid and glucose, which is controlled by the PDC. The PDC converts pyruvate, coenzyme A (CoA), and oxidized nicotinamide adenine dinucleotide (NAD(+)) into acetyl-CoA, reduced form of nicotinamide adenine dinucleotide (NADH), and carbon dioxide. The activity of the PDC is up- and down-regulated by pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase, respectively. In addition, pyruvate is a key intermediate of glucose oxidation and an important precursor for the synthesis of glucose, glycerol, fatty acids, and nonessential amino acids.

Keywords: Diabetes mellitus; Obesity; Pyruvate dehydrogenase (acetyl-transferring) kinase

References

  1. Curr Drug Targets Immune Endocr Metabol Disord. 2002 Jul;2(2):151-65 - PubMed
  2. J Biol Chem. 1998 Jul 10;273(28):17680-8 - PubMed
  3. Mol Cell Endocrinol. 2010 Feb 5;315(1-2):159-67 - PubMed
  4. PLoS One. 2013 Aug 05;8(8):e71997 - PubMed
  5. J Clin Invest. 2004 Jul;114(2):147-52 - PubMed
  6. Acta Physiol (Oxf). 2014 Feb;210(2):392-402 - PubMed
  7. Biochem J. 1998 Jan 1;329 ( Pt 1):191-6 - PubMed
  8. Metabolism. 2012 Feb;61(2):175-85 - PubMed
  9. Biochem J. 2009 Sep 25;423(2):243-52 - PubMed
  10. Nutr Metab (Lond). 2014 Feb 12;11(1):10 - PubMed
  11. Biochem J. 1998 Jan 1;329 ( Pt 1):197-201 - PubMed
  12. Circ Heart Fail. 2012 Jul 1;5(4):493-503 - PubMed
  13. Biochem J. 2012 May 1;443(3):829-39 - PubMed
  14. Bone. 2012 Jan;50(1):409-19 - PubMed
  15. Chin Med J (Engl). 2010 Sep;123(17):2358-63 - PubMed
  16. J Biol Chem. 2011 Jul 8;286(27):23799-807 - PubMed
  17. Hum Mol Genet. 2013 Apr 1;22(7):1404-16 - PubMed
  18. Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H936-43 - PubMed
  19. Diabetes Metab Rev. 1998 Dec;14(4):263-83 - PubMed
  20. Cardiovasc Res. 2012 May 1;94(2):359-69 - PubMed
  21. J Mol Med (Berl). 2013 Mar;91(3):333-46 - PubMed
  22. Eur J Biochem. 1996 Feb 15;236(1):68-77 - PubMed
  23. Diabetes. 1999 Aug;48(8):1593-9 - PubMed
  24. Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E46-54 - PubMed
  25. Rev Endocr Metab Disord. 2014 Mar;15(1):99-110 - PubMed
  26. Diabetes. 2007 May;56(5):1410-20 - PubMed
  27. J Appl Physiol (1985). 2005 Jan;98(1):100-7 - PubMed
  28. Biochem Soc Trans. 2003 Dec;31(Pt 6):1143-51 - PubMed
  29. Arch Biochem Biophys. 2000 Sep 1;381(1):1-7 - PubMed
  30. Diabetes. 2001 Dec;50(12):2729-36 - PubMed
  31. J Biol Chem. 2006 Jul 14;281(28):19772-80 - PubMed
  32. Sci Transl Med. 2010 May 12;2(31):31ra34 - PubMed
  33. J Physiol. 2012 Dec 15;590(24):6389-402 - PubMed
  34. Physiol Genomics. 2005 Mar 21;21(1):34-42 - PubMed
  35. Diabetes Metab J. 2012 Oct;36(5):328-35 - PubMed
  36. Diabetes. 2004 Apr;53(4):899-910 - PubMed
  37. Diabetes. 2006 Aug;55(8):2311-7 - PubMed
  38. Cancer Res. 2013 Dec 15;73(24):7277-89 - PubMed
  39. Diabetes. 2012 Oct;61(10):2484-94 - PubMed
  40. Diabetes. 2002 Feb;51(2):276-83 - PubMed
  41. Life Sci. 2000 Dec 22;68(5):497-503 - PubMed
  42. Diabetes. 2011 Jan;60(1):80-7 - PubMed
  43. Mol Cell Biol. 2012 May;32(10):1893-907 - PubMed
  44. Am J Physiol Endocrinol Metab. 2001 Dec;281(6):E1151-8 - PubMed

Publication Types